Next Article in Journal
Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug–Drug Interaction Study
Next Article in Special Issue
Evaluation of the Ejection Pressure for Tracking Internal Cracks during Compaction in Bilayer Tablet Formulations Using Experimental and Finite Element Methods
Previous Article in Journal
Changes in Epidemiology and Antibiotic Prescription of Influenza: Before and after the Emergence of COVID-19
Previous Article in Special Issue
The Effect of Compression Pressure on the First Layer Surface Roughness and Delamination of Metformin and Evogliptin Bilayer and Trilayer Tablets
 
 
Article

Article Versions Notes

Pharmaceuticals 2024, 17(2), 180; https://doi.org/10.3390/ph17020180
Action Date Notes Link
article xml file uploaded 30 January 2024 13:24 CET Original file -
article xml uploaded. 30 January 2024 13:24 CET Update https://www.mdpi.com/1424-8247/17/2/180/xml
article pdf uploaded. 30 January 2024 13:24 CET Version of Record https://www.mdpi.com/1424-8247/17/2/180/pdf
article supplementary file uploaded. 30 January 2024 13:24 CET - https://www.mdpi.com/1424-8247/17/2/180#supplementary
article html file updated 30 January 2024 13:25 CET Original file https://www.mdpi.com/1424-8247/17/2/180/html
Back to TopTop